Dunvegan Associates’s Elevance Health ELV Stock Holding History

Dunvegan Associates’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$102K	Hold	735	–	–	0.12%	68
2015 Q3	$103K	Hold	735	–	–	0.12%	67
2015 Q2	$121K	Hold	735	–	–	0.13%	60
2015 Q1	$113K	Hold	735	–	–	0.1%	83
2014 Q4	$92K	Hold	735	–	–	0.08%	81
2014 Q3	$88K	Hold	735	–	–	0.08%	78
2014 Q2	$79K	Hold	735	–	–	0.07%	80
2014 Q1	$73K	Buy	+735	New	+$66.5K	0.06%	83

Other funds holding ELV

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $33B AUM 40.62% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Dunvegan Associates's ELV Position: Q4 2015 in Review

Dunvegan Associates held its Elevance Health (ELV) position steady in Q4 2015 at 735 shares worth $102K. The position accounts for 0.12% of the portfolio, ranked #68.

Dunvegan Associates first reported a position in ELV in Q1 2014 and has held it in 8 quarters since. The position peaked at $121K in Q2 2015. 766 funds tracked by Wall St. Rank hold ELV as of Q4 2015.

Dunvegan Associates held 735 shares of Elevance Health worth $102K as of Q4 2015.
Dunvegan Associates left its Elevance Health share count unchanged in Q4 2015.
Elevance Health made up 0.12% of Dunvegan Associates's portfolio in Q4 2015, its #68 holding.
Dunvegan Associates first reported a position in Elevance Health in Q1 2014 and has held it in 8 quarters since.
Dunvegan Associates's Elevance Health position peaked at $121K in Q2 2015.
766 funds tracked by Wall St. Rank held Elevance Health as of Q4 2015.

Based on Dunvegan Associates's 13F filing for Q4 2015, filed 28 Apr 2017.